Fisher and Paykel Healthcare
fphcare.comTotal trials
83
Active
10
Phase 3
1
Total enrollment
3,341
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Obstructive Sleep Apnea48
- Sleep Disordered Breathing10
- Sleep Apnea, Obstructive10
- COPD4
- Obstructive Sleep Apnea (OSA)3
- Obesity Hypoventilation Syndrome3
- Healthy Volunteers3
- COPD (Chronic Obstructive Pulmonary Disease)2
Frequently asked questions about Fisher and Paykel Healthcare
- How many clinical trials does Fisher and Paykel Healthcare have on ClinicalTrials.gov?
- Fisher and Paykel Healthcare is listed as the lead sponsor on 83 clinical trials in ClinicalTrials.gov, 10 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Fisher and Paykel Healthcare's trials are in Phase 3?
- 1 of Fisher and Paykel Healthcare's trials are in Phase 3.
- What therapeutic areas does Fisher and Paykel Healthcare focus on?
- Fisher and Paykel Healthcare's most-studied conditions on ClinicalTrials.gov are Obstructive Sleep Apnea, Sleep Disordered Breathing, Sleep Apnea, Obstructive, COPD, Obstructive Sleep Apnea (OSA).